"Surgical robotics is quietly becoming an artificial intelligence story. Every robotic procedure generates structured video, kinematic, and outcomes data that platforms feed back into surgeon training, intraoperative guidance, and predictive analytics. That flywheel is the moat. The three companies owning the installed bases to build it are Intuitive Surgical ( NASDAQ: ISRG | ISRG Price Prediction), Medtronic ( NYSE: MDT), and Stryker ( NYSE: SYK). With all three trading well off their 2026 highs, the AI sleeper thesis looks more compelling."
"Stryker is the diversified medtech giant with the Mako robotic orthopedic franchise. Q1 FY26 showed adjusted EPS of $2.60, which missed the $2.98 estimate, as well as revenue of $6.02 billion, which came in short of the $6.33 billion consensus. CEO Kevin Lobo cited a March 11, 2026, cybersecurity incident and $118 million in structural optimization charges that compressed adjusted operating margin to 21.1% from 22.9%."
"The AI angle lives in the newly carved-out Ortho Tech business, which combines Mako robotic-assisted surgery with power tools, cutting accessories, and enabling technologies. Knees grew 4.7% and hips 3.7%, both Mako-tethered categories. Lobo said, "I am pleased with our team's ability to recover quickly from the cyber incident.... We remain committed to meeting our full year guidance." Guidance was maintained at 8.0% to 9.5% organic sales growth and adjusted EPS of $14.90 to $15.10."
"Medtronic took its biggest step into the robotics race when the Hugo robotic-assisted surgery system received U.S. FDA clearance, with first cases completed in February 2026. Q3 FY26 revenue of $9.017 billion beat the $8.892 billion estimate, and non-GAAP EPS of $1.36 topped the $1.3351 consensus. Cardiac Ablation"
Surgical robotics is increasingly tied to artificial intelligence through the data produced by robotic procedures. Structured video, kinematic information, and outcomes can be fed back into surgeon training, intraoperative guidance, and predictive analytics. This creates a flywheel that can act as a competitive moat for companies with large installed bases. Intuitive Surgical, Medtronic, and Stryker are positioned as key owners of these installed bases. Stryker’s Mako robotic orthopedic franchise is paired with an Ortho Tech business that includes power tools, cutting accessories, and enabling technologies, with knee and hip growth tied to Mako. Medtronic’s Hugo system received U.S. FDA clearance and began first cases in February 2026.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]